Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours Β· Estimated delivery Aug 16 - Aug 21
GLP-1R CNS expression confirmed in humans Nature Metabolism Safety Data Safety Profile from Research What preclinical and early clinical studies report Preclinical Safety Summary GI toleranceBetter than GLP-1 mono at equivalent doses (preclinical) Hypoglycemia riskLow glucose-dependent insulin release Organ toxicityNone observed in preclinical models GLP-1 safety classWell-established class safety profile Receptor bindingBalanced affinity no single-receptor overdominance Regulatory & Risk Considerations FDA statusUnapproved research use only GI effectsNausea, vomiting (class effect) possible PancreatitisTheoretical GLP-1 class risk Heart rateMild elevation (glucagon component) Long-term effectsUnknown novel triple combination Cancer riskTheoretical thyroid C-cell risk (GLP-1 class, rodents only) The triple agonist approach (GLP-1R + GIPR + GcgR) is the frontier of metabolic peptide research
Distribute this across 3-4 meals (25-40g per meal) for optimal muscle protein synthesis throughout the day
(PubMed) Lever M, George PM, Elmslie JL, et al
The biophysical properties of the stroma, like the cell communication between all the components of the stroma of the tumor prostate, play a critical role not only in the progression of the disease but also in the resistance of the tumor to radiation or cytotoxic therapy
I'm back for round 2 after taking a little time off and can't wait for my results
Keep in mind that, while rare, serious side effects can occur, such as allergic reactions
US$ 26.61
US$ 25.52
US$ 25.74
US$ 20.84
